The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, JH Ahn, JY Jang, SY Cho, MG Kang… - Journal of thrombosis …, 2020 - Springer
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease.
JS Bae, JH Ahn, JY Jang, SY Cho… - … of Thrombosis and …, 2020 - europepmc.org
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
[PDF][PDF] The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, JH Ahn, JY Jang, SY Cho… - Journal of thrombosis …, 2020 - drive.google.com
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
[引用][C] The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, JH Ahn, JY Jang, SY Cho, MG Kang… - Journal of Thrombosis …, 2020 - cir.nii.ac.jp
The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral
artery disease in patients with significant coronary artery disease | CiNii Research CiNii 国立 …
artery disease in patients with significant coronary artery disease | CiNii Research CiNii 国立 …
The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, JH Ahn, JY Jang, SY Cho, MG Kang, KH Kim… - 2020 - scholarworks.gnu.ac.kr
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, JH Ahn, JY Jang, SY Cho… - … of thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
JS Bae, A Jong-Hwa, JJ Yoon… - … of Thrombosis and …, 2020 - search.proquest.com
Patients with peripheral artery disease (PAD) have shown the increased risk of
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …
cardiovascular (CV) morbidity and mortality. This study sought to evaluate the impact of clot …